OSCR

Antisense oligonucleotide-mediated knockdown therapy in two infants with severe KCNT1 epileptic encephalopathy.

Overview

Authors: Tojo Nakayama1,2, Christelle M El Achkar3, Lisseth E Burbano1,4, Imran H Quraishi5,6, Jing Wu6, Melody Li4, Yutaro Asami1,2, Sean R Golinski7, Emma Sherrill1, Benjamin D Goodlett1, Claudio M de Gusmao3, Danielle A Friedman1, Claudia Lentucci1, Victoria Suslovitch1, Olivia Riccardi1, Kamli N W Faour1, Ashley Kuniholm8, Aubrie Soucy Verran1, Siobhan Coffman9, Banu Ahtam10
and 15 other authorsBoxun Zhao1,11,12,13, Diana H Chin1, Renata L DiDonato1, Chunguang A Hu1, Edith Lopez1, Sonia Hills1, Snezana Maljevic4, Helene Tran14, Lynn W Bush1,12, Patricia Ellen Grant10,12, Joseph R Madsen12,15, Richard S Smith7, Leonard K Kaczmarek6,16, Charles B Berde9,12, Timothy W Yu1,11,12,13
16 affiliations
  1. Division of Genetics and Genomics, Boston Children’s Hospital, Boston, MA USA
  2. Nucleotide and Peptide Drug Discovery Center, Institute of Science Tokyo, Tokyo, Japan
  3. Department of Neurology, Boston Children’s Hospital, Boston, MA USA
  4. The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria Australia
  5. Comprehensive Epilepsy Center, Department of Neurology, Yale School of Medicine, New Haven, CT USA
  6. Department of Pharmacology, Yale School of Medicine, New Haven, CT USA
  7. Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, IL USA
  8. Clinical Research Operations Center, Boston Children’s Hospital, Boston, MA USA
  9. Department of Anesthesia, Critical Care, and Pain Medicine, Boston Children’s Hospital, Boston, MA USA
  10. Department of Radiology, Boston Children’s Hospital, Boston, MA USA
  11. Manton Center for Orphan Disease, Boston Children’s Hospital, Boston, MA USA
  12. Harvard Medical School, Boston, MA USA
  13. Broad Institute of MIT and Harvard, Cambridge, MA USA
  14. R&D Servier Institute Paris-Saclay, Saclay, France
  15. Department of Neurosurgery, Boston Children’s Hospital, Boston, MA USA
  16. Department of Cellular and Molecular Physiology, Yale School of Medicine, New Haven, CT USA
Journal: Nature medicine, volume 32, issue 4, pages 1411-1420
Dates: received 30 August 2024; accepted 26 February 2026; published online 14 April 2026; in print 2026
Type: Research article · Language: English
License: CC BY-NC-ND
Identifiers: DOI 10.1038/s41591-026-04314-9 · PMID 41981306 · PMCID PMC13099374 · OpenAlex W7154360999
Open access: hybrid, a free copy (OpenAlex)
Categories: human (organism), other condition (population), epilepsy (population)
Methods: Statistics, Smoothing, state filtering, decompositions
Keywords: Epilepsy, Drug development, Genetics research
MeSH: Epilepsy*, Nerve Tissue Proteins*, Oligonucleotides, Antisense*, Potassium Channels*, Child, Preschool, Female, Gene Knockdown Techniques, Humans, Infant, Potassium Channels, Sodium-Activated, Seizures (* major topic)
Topic: Ion channel regulation and function (Molecular Biology, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Funding: NINDS NIH HHS (R00 NS112604, R01 NS102239); NCATS NIH HHS (UL1 TR000170); NHGRI NIH HHS (R01 HG012247)
Citations: cited by 7 papers (Europe PMC); 60 references in the paper

Abstract

The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability statement

The paper has a data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:

Read it in the paper: doi.org/10.1038/s41591-026-04314-9.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 29 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 35 authors, 3 keywords, 11 MeSH terms, 3 funders, 52 references.

Cite

This paper

Nakayama, T., El Achkar, C. M., Burbano, L. E., Quraishi, I. H., Wu, J., Li, M., Asami, Y., Golinski, S. R., Sherrill, E., Goodlett, B. D., de Gusmao, C. M., Friedman, D. A., Lentucci, C., Suslovitch, V., Riccardi, O., Faour, K. N. W., Kuniholm, A., Soucy Verran, A., Coffman, S., . . . Yu, T. W. (2026). Antisense oligonucleotide-mediated knockdown therapy in two infants with severe KCNT1 epileptic encephalopathy. Nature medicine, 32(4), 1411-1420. https://doi.org/10.1038/s41591-026-04314-9

BibTeX

@article{nakayama2026antisense,
author = {Nakayama, Tojo and El Achkar, Christelle M and Burbano, Lisseth E and Quraishi, Imran H and Wu, Jing and Li, Melody and Asami, Yutaro and Golinski, Sean R and Sherrill, Emma and Goodlett, Benjamin D and de Gusmao, Claudio M and Friedman, Danielle A and Lentucci, Claudia and Suslovitch, Victoria and Riccardi, Olivia and Faour, Kamli N W and Kuniholm, Ashley and Soucy Verran, Aubrie and Coffman, Siobhan and Ahtam, Banu and Zhao, Boxun and Chin, Diana H and DiDonato, Renata L and Hu, Chunguang A and Lopez, Edith and Hills, Sonia and Maljevic, Snezana and Tran, Helene and Bush, Lynn W and Grant, Patricia Ellen and Madsen, Joseph R and Smith, Richard S and Kaczmarek, Leonard K and Berde, Charles B and Yu, Timothy W},
title = {{Antisense oligonucleotide-mediated knockdown therapy in two infants with severe KCNT1 epileptic encephalopathy}},
journal = {Nature medicine},
year = {2026},
month = apr,
volume = {32},
number = {4},
pages = {1411--1420},
publisher = {Nature Portfolio},
issn = {1078-8956},
doi = {10.1038/s41591-026-04314-9},
url = {https://doi.org/10.1038/s41591-026-04314-9},
pmid = {41981306},
pmcid = {PMC13099374}
}

RIS

TY - JOUR
AU - Nakayama, Tojo
AU - El Achkar, Christelle M
AU - Burbano, Lisseth E
AU - Quraishi, Imran H
AU - Wu, Jing
AU - Li, Melody
AU - Asami, Yutaro
AU - Golinski, Sean R
AU - Sherrill, Emma
AU - Goodlett, Benjamin D
AU - de Gusmao, Claudio M
AU - Friedman, Danielle A
AU - Lentucci, Claudia
AU - Suslovitch, Victoria
AU - Riccardi, Olivia
AU - Faour, Kamli N W
AU - Kuniholm, Ashley
AU - Soucy Verran, Aubrie
AU - Coffman, Siobhan
AU - Ahtam, Banu
AU - Zhao, Boxun
AU - Chin, Diana H
AU - DiDonato, Renata L
AU - Hu, Chunguang A
AU - Lopez, Edith
AU - Hills, Sonia
AU - Maljevic, Snezana
AU - Tran, Helene
AU - Bush, Lynn W
AU - Grant, Patricia Ellen
AU - Madsen, Joseph R
AU - Smith, Richard S
AU - Kaczmarek, Leonard K
AU - Berde, Charles B
AU - Yu, Timothy W
TI - Antisense oligonucleotide-mediated knockdown therapy in two infants with severe KCNT1 epileptic encephalopathy
T2 - Nature medicine
J2 - Nat Med
PY - 2026
DA - 2026/04/14
VL - 32
IS - 4
SP - 1411
EP - 1420
SN - 1078-8956
PB - Nature Portfolio
DO - 10.1038/s41591-026-04314-9
UR - https://doi.org/10.1038/s41591-026-04314-9
LA - en
ER -

CSL-JSON

{
"id": "10.1038/s41591-026-04314-9",
"type": "article-journal",
"title": "Antisense oligonucleotide-mediated knockdown therapy in two infants with severe KCNT1 epileptic encephalopathy",
"container-title": "Nature medicine",
"author": [
{
"family": "Nakayama",
"given": "Tojo"
},
{
"family": "El Achkar",
"given": "Christelle M"
},
{
"family": "Burbano",
"given": "Lisseth E"
},
{
"family": "Quraishi",
"given": "Imran H"
},
{
"family": "Wu",
"given": "Jing"
},
{
"family": "Li",
"given": "Melody"
},
{
"family": "Asami",
"given": "Yutaro"
},
{
"family": "Golinski",
"given": "Sean R"
},
{
"family": "Sherrill",
"given": "Emma"
},
{
"family": "Goodlett",
"given": "Benjamin D"
},
{
"family": "de Gusmao",
"given": "Claudio M"
},
{
"family": "Friedman",
"given": "Danielle A"
},
{
"family": "Lentucci",
"given": "Claudia"
},
{
"family": "Suslovitch",
"given": "Victoria"
},
{
"family": "Riccardi",
"given": "Olivia"
},
{
"family": "Faour",
"given": "Kamli N W"
},
{
"family": "Kuniholm",
"given": "Ashley"
},
{
"family": "Soucy Verran",
"given": "Aubrie"
},
{
"family": "Coffman",
"given": "Siobhan"
},
{
"family": "Ahtam",
"given": "Banu"
},
{
"family": "Zhao",
"given": "Boxun"
},
{
"family": "Chin",
"given": "Diana H"
},
{
"family": "DiDonato",
"given": "Renata L"
},
{
"family": "Hu",
"given": "Chunguang A"
},
{
"family": "Lopez",
"given": "Edith"
},
{
"family": "Hills",
"given": "Sonia"
},
{
"family": "Maljevic",
"given": "Snezana"
},
{
"family": "Tran",
"given": "Helene"
},
{
"family": "Bush",
"given": "Lynn W"
},
{
"family": "Grant",
"given": "Patricia Ellen"
},
{
"family": "Madsen",
"given": "Joseph R"
},
{
"family": "Smith",
"given": "Richard S"
},
{
"family": "Kaczmarek",
"given": "Leonard K"
},
{
"family": "Berde",
"given": "Charles B"
},
{
"family": "Yu",
"given": "Timothy W"
}
],
"container-title-short": "Nat Med",
"volume": "32",
"issue": "4",
"page": "1411-1420",
"DOI": "10.1038/s41591-026-04314-9",
"PMID": "41981306",
"PMCID": "PMC13099374",
"ISSN": "1078-8956",
"publisher": "Nature Portfolio",
"URL": "https://doi.org/10.1038/s41591-026-04314-9",
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
14
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41467-026-72334-7 [code]
RNA targeting therapy for a prenatally enriched potassium channel associated with severe childhood epilepsy and premature death.
Journal: Nature communications
In common: epilepsy, 17 references, 2 authors
[2] doi:10.1126/sciadv.adv3140 [code]
Neuronal potassium channel activity triggers initiation of mRNA translation through binding of translation regulators.
Journal: Science advances
In common: other condition, 6 references, 2 authors
[3] doi:10.1016/j.celrep.2024.113904
Disease-causing Slack potassium channel mutations produce opposite effects on excitability of excitatory and inhibitory neurons.
Journal: Cell reports
In common: epilepsy, 6 references, 2 authors
[4] doi:10.1016/j.omtn.2024.102161
Favorable efficacy and reduced acute neurotoxicity by antisense oligonucleotides with 2',4'-BNA/LNA with 9-(aminoethoxy)phenoxazine.
Journal: Molecular therapy. Nucleic acids
In common: 5 references
[5] doi:10.1016/j.omtn.2025.102815 [code]
Atrophin-1 antisense oligonucleotide provides robust protection from pathology in a fully humanized DRPLA model.
Journal: Molecular therapy. Nucleic acids
In common: 1 reference, author Timothy W. Yu
[6] doi:10.1038/s41467-024-52463-7 [code]
A cell type-aware framework for nominating non-coding variants in Mendelian regulatory disorders.
Journal: Nature communications
In common: 2 references, author Boxun Zhao
[7] doi:10.1016/j.ymthe.2025.05.010
RNAi-mediated silencing of SOD1 profoundly extends survival and functional outcomes in ALS mice.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
In common: other condition, 4 references
[8] doi:10.1038/s41588-026-02570-6 [code]
Somatic mosaicism in ALS and FTD identifies focal mutations associated with widespread degeneration.
Journal: Nature genetics
In common: other condition, 1 reference, author Boxun Zhao
[9] doi:10.1172/jci197271 [code]
Alternative splicing-triggered mRNA decay informs splice-switching targets for neurodevelopmental disorders.
Journal: The Journal of clinical investigation
In common: epilepsy, other condition, 5 references
[10] doi:10.1016/j.devcel.2022.09.011
Loss of non-motor kinesin KIF26A causes congenital brain malformations via dysregulated neuronal migration and axonal growth as well as apoptosis.
Journal: Developmental cell
In common: author Richard S. Smith

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.